Hemogenyx Pharmaceuticals PLC Announces Total Voting Rights

Core Viewpoint - Hemogenyx Pharmaceuticals plc has announced its total issued share capital and the number of voting rights as of February 27, 2026, indicating a stable share structure for the company [1]. Group 1 - The total issued share capital of Hemogenyx Pharmaceuticals consists of 6,425,429 ordinary shares, each with a nominal value of 1 penny [1]. - There are no shares held in treasury, which means all issued shares are available for voting [1]. - The total number of voting rights in the company is equal to the total issued shares, amounting to 6,425,429 [1].